McCarthy, EM;
Sutton, E;
Nesbit, S;
Ben, P;
Jayne, D;
Griffiths, B;
Isenberg, DA;
... Bruce, IN; + view all
(2017)
The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales.
Rheumatology
, 56
(6)
pp. 1041-1043.
10.1093/rheumatology/kex044.
Preview |
Text
Rahman_FinalBelimumabLetterRheumatology.pdf - Accepted Version Download (265kB) | Preview |
| Type: | Article |
|---|---|
| Title: | The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1093/rheumatology/kex044 |
| Publisher version: | http://doi.org/10.1093/rheumatology/kex044 |
| Language: | English |
| Additional information: | © The Author 2017. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Science & Technology, Life Sciences & Biomedicine, Rheumatology, SYSTEMIC-LUPUS-ERYTHEMATOSUS |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1555153 |
Loading...
Loading...Loading...Loading...Archive Staff Only
 |
View Item |
